Cargando…

Molecular drivers of lobular carcinoma in situ

Lobular carcinoma in situ (LCIS) is considered to be a risk factor for the development of invasive breast carcinoma, but it may also be a non-obligate precursor to invasive lobular carcinoma (ILC). Many LCIS lesions do not progress to ILC, and the molecular changes that are necessary for progression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Logan, Greg J., Dabbs, David J., Lucas, Peter C., Jankowitz, Rachel C., Brown, Daniel D., Clark, Beth Z., Oesterreich, Steffi, McAuliffe, Priscilla F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453073/ https://www.ncbi.nlm.nih.gov/pubmed/26041550 http://dx.doi.org/10.1186/s13058-015-0580-5

Ejemplares similares

Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology
por: Blohmer, Martin, et al.
Publicado: (2020)

Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma
por: Nunes, Raquel, et al.
Publicado: (2021)

Epigenetics in breast cancer: what's new?
por: Huang, Yi, et al.
Publicado: (2011)

Genetic analysis of lobular carcinoma in situ and associated invasive lobular cancer
por: Yates, LR, et al.
Publicado: (2010)

How Researchers, Clinicians and Patient Advocates Can Accelerate Lobular Breast Cancer Research
por: Pate, Leigh, et al.
Publicado: (2021)

Associations between pathologic tumor features and preadjuvant therapy cognitive performance in women diagnosed with breast cancer
por: Koleck, Theresa A., et al.
Publicado: (2017)

Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer
por: Du, Tian, et al.
Publicado: (2018)

Comparison of the Imaging Features of Lobular Carcinoma In Situ and Invasive Lobular Carcinoma of the Breast
Publicado: (2021)

Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions
por: Sflomos, George, et al.
Publicado: (2021)

WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines
por: Sikora, Matthew J., et al.
Publicado: (2016)

Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism
por: Du, Tian, et al.
Publicado: (2018)

Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity?
por: Yu, Jing, et al.
Publicado: (2023)

Response in axillary lymph nodes to neoadjuvant chemotherapy for breast cancers: correlation with breast response, pathologic features, and accuracy of radioactive seed localization
por: Clark, Beth Z., et al.
Publicado: (2023)

Germline CDH1 mutations in bilateral lobular carcinoma in situ
por: Petridis, C, et al.
Publicado: (2014)

FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype
por: Levine, Kevin M., et al.
Publicado: (2019)

Estrogen Regulation of mTOR Signaling and Mitochondrial Function in Invasive Lobular Carcinoma Cell Lines Requires WNT4
por: Shackleford, Madeleine T., et al.
Publicado: (2020)

Molecular Classification of Lobular Carcinoma of the Breast
por: Fu, Denggang, et al.
Publicado: (2017)

Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ
por: Lo, Louisa Lisa, et al.
Publicado: (2018)

Imaging Spectrum of Lobular Carcinoma In Situ and Correlation with Pathology Findings
por: Hande, Pradipta C, et al.
Publicado: (2021)

The diagnosis and management of pre-invasive breast disease: Pathology of atypical lobular hyperplasia and lobular carcinoma in situ
por: Simpson, Peter T, et al.
Publicado: (2003)

Invasive lobular carcinoma with extracellular mucin production and HER-2 overexpression: a case report and further case studies
por: Yu, Jing, et al.
Publicado: (2010)

E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.
por: Vos, C. B., et al.
Publicado: (1997)

THU477 Drivers Of Estrogen Induced Invasive Lobular Carcinoma
por: Ufondu, Chinasa, et al.
Publicado: (2023)

53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression
por: Rothschild, Harriet, et al.
Publicado: (2023)

Proteomic and transcriptomic profiling identifies mediators of anchorage-independent growth and roles of inhibitor of differentiation proteins in invasive lobular carcinoma
por: Tasdemir, Nilgun, et al.
Publicado: (2020)

Granulomatous lobular mastitis associated with ductal carcinoma in situ of the breast
por: Oddó, David, et al.
Publicado: (2019)

Lobular Carcinoma In Situ during Preoperative Biopsy and the Rate of Upgrade
por: Lee, Jeea, et al.
Publicado: (2022)

53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression – CORRIGENDUM
por: Rothschild, Harriet T, et al.
Publicado: (2023)

Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions
por: Andrade, Victor P, et al.
Publicado: (2012)

Clonal relationships between lobular carcinoma in situ and other breast malignancies
por: Begg, Colin B., et al.
Publicado: (2016)

Pleomorphic lobular carcinoma in situ: Current evidence and a systemic review
por: Wazir, Umar, et al.
Publicado: (2016)

Lobular Carcinoma In Situ Incidentally Detected by Dual-Energy Computed Tomography
por: Erdemir, Ahmet Gürkan, et al.
Publicado: (2022)

Breast cancer after prophylactic mastectomy for Lobular Carcinoma-In-Situ (LCIS) - an unusual case
por: Gurjar, N, et al.
Publicado: (2012)

Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene
por: Rahman, N, et al.
Publicado: (2000)

Breast Cancers With Magee Equation Score of Less Than 18, or 18-25 and Mitosis Score of 1, Do Not Require Oncotype DX Testing: A Value Study
por: Bhargava, Rohit, et al.
Publicado: (2019)

The healthcare value of the Magee Decision Algorithm™: use of Magee Equations™ and mitosis score to safely forgo molecular testing in breast cancer
por: Bhargava, Rohit, et al.
Publicado: (2020)

Prognostic Significance of Lobular Carcinoma In-Situ (LCIS) Diagnosed Alongside Invasive Breast Cancer
por: Braasch, Maxwell C, et al.
Publicado: (2022)

The Shrinking Breast: An Unusual Mammographic Finding of Invasive Lobular Carcinoma
por: Jafri, Nazia F., et al.
Publicado: (2015)

4.2: Vacuum biopsy in the management of lobular in situ neoplasia: a single-centre experience
por: Parkin, C, et al.
Publicado: (2013)

Collagenous Spherulosis Associated with Lobular Carcinoma In Situ of the Breast: Two Case Reports
por: Kim, Ga-Eon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bnf6veobt39tg9enfscq5q2tdo